WHO ICTRP trial
Comparison of cilostazol-based triple antiplatelet therapy versus dual…
KCT0002873 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0002873 |
|---|---|
| Public title | Comparison of cilostazol-based triple antiplatelet therapy versus dual antiplatelet therapy for outcomes of below-the knee endovascular intervention in patients with critical limb ischemia (TAP CLI study) |
| Scientific title | Comparison of cilostazol-based triple antiplatelet therapy versus dual antiplatelet therapy for outcomes of below-the knee endovascular intervention in patients with critical limb ischemia (TAP CLI study) |
| Primary sponsor | Yonsei University Health System, Severance Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Diseases of the circulatory system |
| Interventions | Drug : Patient group with dual antiplatelet therapy using aspirin and clopidogrel (DAP (Dual antiplatelet therapy)A) for 12month(An oral dose once a day) Patient group with angioplasty using aspirin and cilostazol (DAP (Dual antiplatelet… |
| Registration date | May 17, 2018 |
| Target size | 390 |
| Secondary IDs | NCT02829151 |
| Registry page | cris.nih.go.kr |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: